tiprankstipranks
Trending News
More News >
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market
Advertisement

Evofem Biosciences (EVFM) Price & Analysis

Compare
1,214 Followers

EVFM Stock Chart & Stats


Evofem Biosciences News

EVFM FAQ

What was Evofem Biosciences’s price range in the past 12 months?
Evofem Biosciences lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
    What is Evofem Biosciences’s market cap?
    Evofem Biosciences’s market cap is $1.72M.
      When is Evofem Biosciences’s upcoming earnings report date?
      Evofem Biosciences’s upcoming earnings report date is Nov 17, 2025 which is in 47 days.
        How were Evofem Biosciences’s earnings last quarter?
        Evofem Biosciences released its earnings results on Aug 14, 2025. The company reported -$0.015 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.015.
          Is Evofem Biosciences overvalued?
          According to Wall Street analysts Evofem Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Evofem Biosciences pay dividends?
            Evofem Biosciences does not currently pay dividends.
            What is Evofem Biosciences’s EPS estimate?
            Evofem Biosciences’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Evofem Biosciences have?
            Evofem Biosciences has 118,656,360 shares outstanding.
              What happened to Evofem Biosciences’s price movement after its last earnings report?
              Evofem Biosciences reported an EPS of -$0.015 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Evofem Biosciences?
                Currently, no hedge funds are holding shares in EVFM

                Company Description

                Evofem Biosciences

                Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

                Evofem Biosciences (EVFM) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Q/C Technologies
                Daré Bioscience
                Salarius Pharmaceuticals
                XTL Biopharmaceuticals Sponsored ADR
                Qualigen Therapeutics

                Ownership Overview

                <0.01%100.00%
                Insiders
                Mutual Funds
                <0.01% Other Institutional Investors
                100.00% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis